National Human Genome Research Institute; Notice of Meeting, 16378 [2021-06373]

Download as PDF 16378 Federal Register / Vol. 86, No. 58 / Monday, March 29, 2021 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Council for Human Genome Research. The meeting will be open to the public as indicated below, the 93rd meeting of the National Advisory Council for Human Genome Research open session will be livestreamed and available for viewing to the public from https://www.genome.gov/eventcalendar/93rd-Meeting-of-NationalAdvisory-Council-for-Human-GenomeResearch. The open session will be on May 17th and the start time will be 11:30 a.m. The portion of the meeting will also be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council for Human Genome Research. Date: May 17–18, 2021. Closed: May 17, 2021, 10:00 a.m. to 11:00 a.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Suite 1100, Bethesda, MD 20892 (Virtual Meeting). Open: May 17, 2021, 11:30 a.m. to 5:00 p.m. Agenda: Report from Institute Director and Program Staff. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Suite 1100, Bethesda, MD 20892 (Virtual Meeting). Closed: May 18, 2021, 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Suite 1100, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review Officer, Scientific Review Branch, National Human Genome Research Institute, 6700B Rockledge Drive, Suite 1100, Bethesda, MD 20892, (301) 402–0838, pozzattr@mail.nih.gov. Any interested person may file written comments within 15 days after the meeting VerDate Sep<11>2014 17:20 Mar 26, 2021 Jkt 253001 with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.genome.gov/council, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Dated: March 23, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Michelle Marie Arnold, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301–435–1199, michelle.arnold@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) [FR Doc. 2021–06373 Filed 3–26–21; 8:45 am] Dated: March 23, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P [FR Doc. 2021–06375 Filed 3–26–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Mycology, Parasitology and Pathogenesis. Date: April 23, 2021. Time: 11:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Kenneth M. Izumi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3204, MSC 7808, Bethesda, MD 20892, 301–496– 6980, izumikm@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Microbiota and Mucosal Immunity. Date: April 29, 2021. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke Amended; Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute of Neurological Disorders and Stroke Special Emphasis Panel, April 01, 2021, 10:00 a.m. to April 02, 2021, 06:00 p.m., National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 which was published in the Federal Register on February 26, 2021, 86 FR 11783. This notice is being amended to make this two-day meeting a three-day meeting. The meeting will now be held from March 31, 2021 to April 2, 2021. The meeting time remains the same. The meeting is closed to the public. Dated: March 23, 2021. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–06367 Filed 3–26–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2021–0187] National Merchant Mariner Medical Advisory Committee; April 2021 Teleconference U.S. Coast Guard, Department of Homeland Security. AGENCY: E:\FR\FM\29MRN1.SGM 29MRN1

Agencies

[Federal Register Volume 86, Number 58 (Monday, March 29, 2021)]
[Notices]
[Page 16378]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-06373]



[[Page 16378]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Human Genome Research Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Advisory 
Council for Human Genome Research.
    The meeting will be open to the public as indicated below, the 93rd 
meeting of the National Advisory Council for Human Genome Research open 
session will be livestreamed and available for viewing to the public 
from https://www.genome.gov/event-calendar/93rd-Meeting-of-National-Advisory-Council-for-Human-Genome-Research. The open session will be on 
May 17th and the start time will be 11:30 a.m.
    The portion of the meeting will also be closed to the public in 
accordance with the provisions set forth in sections 552b(c)(4) and 
552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: National Advisory Council for Human Genome 
Research.
    Date: May 17-18, 2021.
    Closed: May 17, 2021, 10:00 a.m. to 11:00 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Suite 1100, Bethesda, 
MD 20892 (Virtual Meeting).
    Open: May 17, 2021, 11:30 a.m. to 5:00 p.m.
    Agenda: Report from Institute Director and Program Staff.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Suite 1100, Bethesda, 
MD 20892 (Virtual Meeting).
    Closed: May 18, 2021, 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Suite 1100, Bethesda, 
MD 20892 (Virtual Meeting).
    Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review 
Officer, Scientific Review Branch, National Human Genome Research 
Institute, 6700B Rockledge Drive, Suite 1100, Bethesda, MD 20892, 
(301) 402-0838, [email protected].

    Any interested person may file written comments within 15 days 
after the meeting with the committee by forwarding the statement to 
the Contact Person listed on this notice. The statement should 
include the name, address, telephone number and when applicable, the 
business or professional affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: https://www.genome.gov/council, where an agenda and any 
additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human 
Genome Research, National Institutes of Health, HHS)

    Dated: March 23, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-06373 Filed 3-26-21; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.